Americans will soon be able to buy prescription drugs directly from the federal government, according to the White House.
On Tuesday, President Donald Trump announced the launch of a direct-to-consumer website where consumers could purchase discounted drugs. It will be called "TrumpRx."
"It increases transparency; in many instances, prices are 80% lower than they are today," Chris Klomp, the Director of Medicare and Deputy Administrator of CMS, said during the announcement. "No more Canadian detours to purchase drugs more inexpensively at our neighbor. You do it from home. You do it with a click."
Klomp said the website will be launched "soon."
The White House said that "virtually all drugs" will be available on the site. Four specific examples of drugs that will be available are: Eucrisa (a dermatitis drug), Duvaee (a post-menopausal osteoporosis drug), Zavzpret (a migraine drug), and Xeljanz (a rheumatoid arthritis drug). Pfizer makes all four.
PROMISES MADE, PROMISES KEPT: President Trump Delivers LOWER DRUG PRICES for Americans pic.twitter.com/nA4tPrmcXt
— Rapid Response 47 (@RapidResponse47) September 30, 2025
Craig Garthwaite, a health economist at Northwestern University's Kellogg School of Management, said before the official announcement that it's "hard to imagine any large impact on the market."
"Most people need insurance to pay for expensive drugs," Garthwaite wrote on X. "Hard to imagine prices here are lower than net prices. Definitely not lower than most out of pocket payments."
Trump also said that the White House has reached an agreement with Pfizer to sell its drugs to Medicaid at lower prices. Pfizer CEO Albert Bourla joined Trump for the announcements.
In May, Trump signed an executive order pressuring the largest pharmaceutical companies to offer their drugs at "Most Favored Nation status," a model based on the lowest price available in a comparable country.
In July, Trump sent letters to Bourla and 16 other CEOs of major drugmakers, detailing how their companies should cut drug prices based on the executive order. Trump gave CEOs 60 days for their companies to comply with his requests.
This story is developing.
